These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 31555726

  • 1. Multiplexed analysis of the secretin-like GPCR-RAMP interactome.
    Lorenzen E, Dodig-Crnković T, Kotliar IB, Pin E, Ceraudo E, Vaughan RD, Uhlèn M, Huber T, Schwenk JM, Sakmar TP.
    Sci Adv; 2019 Sep; 5(9):eaaw2778. PubMed ID: 31555726
    [Abstract] [Full Text] [Related]

  • 2. Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.
    Kotliar IB, Bendes A, Dahl L, Chen Y, Saarinen M, Ceraudo E, Dodig-Crnković T, Uhlén M, Svenningsson P, Schwenk JM, Sakmar TP.
    Sci Adv; 2024 Aug 02; 10(31):eado9959. PubMed ID: 39083597
    [Abstract] [Full Text] [Related]

  • 3. Expanding the GPCR-RAMP interactome.
    Kotliar IB, Bendes A, Dahl L, Chen Y, Saarinen M, Ceraudo E, Dodig-Crnković T, Uhle'n M, Svenningsson P, Schwenk JM, Sakmar TP.
    bioRxiv; 2023 Nov 23. PubMed ID: 38045268
    [Abstract] [Full Text] [Related]

  • 4. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
    Kotliar IB, Lorenzen E, Schwenk JM, Hay DL, Sakmar TP.
    Pharmacol Rev; 2023 Jan 23; 75(1):1-34. PubMed ID: 36757898
    [Abstract] [Full Text] [Related]

  • 5. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
    Archbold JK, Flanagan JU, Watkins HA, Gingell JJ, Hay DL.
    Trends Pharmacol Sci; 2011 Oct 23; 32(10):591-600. PubMed ID: 21722971
    [Abstract] [Full Text] [Related]

  • 6. Dawn of a New RAMPage.
    Serafin DS, Harris NR, Nielsen NR, Mackie DI, Caron KM.
    Trends Pharmacol Sci; 2020 Apr 23; 41(4):249-265. PubMed ID: 32115276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs.
    Barbash S, Lorenzen E, Persson T, Huber T, Sakmar TP.
    Proc Natl Acad Sci U S A; 2017 Nov 07; 114(45):12015-12020. PubMed ID: 29078385
    [Abstract] [Full Text] [Related]

  • 9. Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.
    Hay DL, Pioszak AA.
    Annu Rev Pharmacol Toxicol; 2016 Nov 07; 56():469-87. PubMed ID: 26514202
    [Abstract] [Full Text] [Related]

  • 10. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
    Pioszak AA, Hay DL.
    Adv Pharmacol; 2020 Nov 07; 88():115-141. PubMed ID: 32416865
    [Abstract] [Full Text] [Related]

  • 11. Modulating effects of RAMPs on signaling profiles of the glucagon receptor family.
    Shao L, Chen Y, Zhang S, Zhang Z, Cao Y, Yang D, Wang MW.
    Acta Pharm Sin B; 2022 Feb 07; 12(2):637-650. PubMed ID: 35256936
    [Abstract] [Full Text] [Related]

  • 12. The effects of RAMPs upon cell signalling.
    Routledge SJ, Ladds G, Poyner DR.
    Mol Cell Endocrinol; 2017 Jul 05; 449():12-20. PubMed ID: 28390954
    [Abstract] [Full Text] [Related]

  • 13. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.
    Kuwasako K, Hay DL, Nagata S, Murakami M, Kitamura K, Kato J.
    Curr Protein Pept Sci; 2013 Aug 05; 14(5):416-28. PubMed ID: 23745705
    [Abstract] [Full Text] [Related]

  • 14. The expanding repertoire of receptor activity modifying protein (RAMP) function.
    Klein KR, Matson BC, Caron KM.
    Crit Rev Biochem Mol Biol; 2016 Aug 05; 51(1):65-71. PubMed ID: 26740457
    [Abstract] [Full Text] [Related]

  • 15. G Protein-Coupled Receptors as Potential Intercellular Communication Mediators in Trypanosomatidae.
    Díaz E, Febres A, Giammarresi M, Silva A, Vanegas O, Gomes C, Ponte-Sucre A.
    Front Cell Infect Microbiol; 2022 Aug 05; 12():812848. PubMed ID: 35651757
    [Abstract] [Full Text] [Related]

  • 16. Regulation of GPCR trafficking by RAMPs.
    Bomberger JM, Parameswaran N, Spielman WS.
    Adv Exp Med Biol; 2012 Aug 05; 744():25-37. PubMed ID: 22434105
    [Abstract] [Full Text] [Related]

  • 17. Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function.
    Qi T, Dong M, Watkins HA, Wootten D, Miller LJ, Hay DL.
    Br J Pharmacol; 2013 Feb 05; 168(3):644-57. PubMed ID: 22946511
    [Abstract] [Full Text] [Related]

  • 18. Receptor activity modifying proteins and their potential as drug targets.
    Wootten DL, Simms J, Hay DL, Christopoulos A, Sexton PM.
    Prog Mol Biol Transl Sci; 2010 Feb 05; 91():53-79. PubMed ID: 20691959
    [Abstract] [Full Text] [Related]

  • 19. RAMPs as drug targets.
    Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL.
    Adv Exp Med Biol; 2012 Feb 05; 744():61-74. PubMed ID: 22434108
    [Abstract] [Full Text] [Related]

  • 20. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
    Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, Christopoulos A.
    Ann N Y Acad Sci; 2006 Jul 05; 1070():90-104. PubMed ID: 16888151
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.